BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2018

Jun 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2018-06-20

Reporting Person: INGRAM ROBERT ALEXANDER (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-20	Automatic Stock Option Grant	$6.09	A	30000	Acquired	2028-06-20	Common Stock (30000)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan.

F2: Vests 1/12th per month over twelve months beginning July 20, 2018.